I-Dialectic Therapeutics, Inc., inkampani yase-Texas egxile ekwakhiweni kobuchwepheshe obusha bokwelapha umdlavuza, namuhla imemezele ukuthi i-US Food and Drug Administration (FDA) inikeze igama lesidakamizwa sezintandane ku-DT2216 ukuze zelashwe i-T-cell. i-lymphoma. I-DT2216 iyinhlanganisela yesizukulwane sokuqala se-Dialectic eyakhiwe kusetshenziswa inkundla yobuchwepheshe yayo kanye nenoveli i-Antiapoptotic Protein Targeted Degradation (APTaD™).
“Lesi yingqopha-mlando ekuthuthukisweni kwe-DT2216, inhlanganisela yethu ehamba phambili ye-APTaD™. Isinqumo se-FDA sokunikeza igama lomuthi wezintandane sigcizelela inkolelo yethu yokuthi i-DT2216 ingaba yindlela yokwelapha ethembisayo ezigulini ze-T-cell lymphoma” kusho uDkt. David Genecov, uMongameli we-Dialectic kanye neSikhulu Esiphezulu. "Kunesidingo esibalulekile esingafinyeleleki sabantu abatholakala benomdlavuza ongandile, lapho izindlela zokwelapha ezigunyaziwe zinezilinganiso zokuphendula eziphansi kakhulu".
Ama-T-cell ajwayelekile adinga isisho se-BCL-XL ukuze asinde ekukhethweni kwe-thymic phakathi nokukhula kwawo. Ngemva kokukhetha i-thymic BCL-XL ama-T-cell avamile awasavezi i-BCL-XL. Kodwa-ke, ama-T-cell lymphomas amaningi aphinde aveze i-BCL-XL njengendlela yokuguqulwa kwe-neoplastic futhi avumele ukuqhubeka kwawo ephila njengesifo esiyingozi. Ucwaningo luye lwabonisa ukubaluleka kwe-BCL-XL ekusindeni kwe-T-cell lymphoma. I-Dialectic ibonise ukuthi i-DT2216 iwukwelapha okusebenzayo kwe-T-cell lymphoma ezifundweni zangaphambi komtholampilo.
Ihhovisi le-FDA's Office of Orphan Products Development linikeza isimo sokuqokwa kwentandane kuzidakamizwa nesayensi yezinto eziphilayo ezihloselwe ukwelashwa okuphephile nokusebenzayo, ukuxilonga noma ukuvimbela izifo ezingandile, noma izimo ezithinta abantu abangaphansi kuka-200,000 ekuqokweni kwezidakamizwa ze-US Orphan kunikeza izinzuzo ezithile, okuhlanganisa nokugqugquzela ngokwezimali ukusekela ukuthuthukiswa komtholampilo kanye namandla afinyelela eminyakeni eyisikhombisa yokukhethekile emakethe e-US ngemva kokugunyazwa ngokomthetho.